Technology ❯Biotechnology ❯Genetic Engineering
Genetic Engineering Cancer Treatment mRNA Technology Funding Cuts Treatment Clinical Trials Virology Cancer Care Infectious Diseases Medical Technology
Approved by both companies’ boards, the all-stock acquisition is slated to close in 2025 pending regulatory approval.